163 related articles for article (PubMed ID: 3017406)
1. Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase.
Krstenansky JL; Trivedi D; Hruby VJ
Biochemistry; 1986 Jul; 25(13):3833-9. PubMed ID: 3017406
[TBL] [Abstract][Full Text] [Related]
2. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
[TBL] [Abstract][Full Text] [Related]
3. Monoiodoglucagon: synthesis, purification by high pressure liquid chromatography, and characteristics as a receptor probe.
Rojas FJ; Swartz TL; Iyengar R; Garber AJ; Birnbaumer L
Endocrinology; 1983 Aug; 113(2):711-9. PubMed ID: 6307649
[TBL] [Abstract][Full Text] [Related]
4. Effect of specific trinitrophenylation of the lysine epsilon amino group of glucagon on receptor binding and adenylate cyclase activation.
Liepnieks JJ; Epand RM
Arch Biochem Biophys; 1983 Aug; 225(1):102-9. PubMed ID: 6311099
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. Study of chemically modified forms of the hormone, including N alpha-trinitrophenyl glucagon, an antagonist.
Epand RM; Rosselin G; Hoa DH; Cote TE; Laburthe M
J Biol Chem; 1981 Feb; 256(3):1128-32. PubMed ID: 6256384
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of glucagon partial agonists and antagonists.
Gysin B; Trivedi D; Johnson DG; Hruby VJ
Biochemistry; 1986 Dec; 25(25):8278-84. PubMed ID: 3814583
[TBL] [Abstract][Full Text] [Related]
7. Synthetic peptide antagonists of glucagon.
Unson CG; Andreu D; Gurzenda EM; Merrifield RB
Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
[TBL] [Abstract][Full Text] [Related]
8. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
Liepnieks JJ; Epand RM
Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
[TBL] [Abstract][Full Text] [Related]
9. Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).
Frandsen EK; Thim L; Moody AJ; Markussen J
J Biol Chem; 1985 Jun; 260(12):7581-4. PubMed ID: 2987259
[TBL] [Abstract][Full Text] [Related]
10. Glucagon antagonists: contribution to binding and activity of the amino-terminal sequence 1-5, position 12, and the putative alpha-helical segment 19-27.
Unson CG; Gurzenda EM; Iwasa K; Merrifield RB
J Biol Chem; 1989 Jan; 264(2):789-94. PubMed ID: 2536024
[TBL] [Abstract][Full Text] [Related]
11. The glucagon receptor from liver can be functionally fused to caudate nucleus adenylate cyclase.
Tolkovsky AM; Martin BR
FEBS Lett; 1982 Dec; 150(2):337-42. PubMed ID: 6297980
[No Abstract] [Full Text] [Related]
12. The role of nonspecific hydrophobic interactions in the biological activity of N epsilon-acyl derivatives of glucagon. Studies of conformation, receptor binding, and adenylate cyclase activation.
Carrey EA; Epand RM
J Biol Chem; 1982 Sep; 257(18):10624-30. PubMed ID: 6286664
[TBL] [Abstract][Full Text] [Related]
13. Importance of the C-terminal alpha-helical structure for glucagon's biological activity.
Krstenansky JL; Zechel C; Trivedi D; Hruby VJ
Int J Pept Protein Res; 1988 Dec; 32(6):468-75. PubMed ID: 2854536
[TBL] [Abstract][Full Text] [Related]
14. Glucagon: structure-function relationships investigated by sequence deletions.
Frandsen EK; Grønvald FC; Heding LG; Johansen NL; Lundt BF; Moody AJ; Markussen J; Vølund A
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):665-77. PubMed ID: 6268519
[TBL] [Abstract][Full Text] [Related]
15. Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase.
Hoosein NM; Gurd RS
FEBS Lett; 1984 Dec; 178(1):83-6. PubMed ID: 6094259
[TBL] [Abstract][Full Text] [Related]
16. Preparation of 2-thioltryptophan-glucagon and (tryptophan-S-glucagon)2. Differences in binding to the glucagon receptor in the hepatic adenylate cyclase system.
Wright DE; Rodbell M
J Biol Chem; 1980 Nov; 255(22):10884-7. PubMed ID: 7430160
[TBL] [Abstract][Full Text] [Related]
17. Topographical amino acid substitution in position 10 of glucagon leads to antagonists/partial agonists with greater binding differences.
Azizeh BY; Shenderovich MD; Trivedi D; Li G; Sturm NS; Hruby VJ
J Med Chem; 1996 Jun; 39(13):2449-55. PubMed ID: 8691441
[TBL] [Abstract][Full Text] [Related]
18. Properties of amidinated glucagons.
Wright DE; Rodbell M
Eur J Biochem; 1980 Oct; 111(1):11-6. PubMed ID: 7439177
[TBL] [Abstract][Full Text] [Related]
19. New glucagon analogues with conformational restrictions and altered amphiphilicity: effects on binding, adenylate cyclase and glycogenolytic activities.
Hruby VJ; Gysin B; Trivedi D; Johnson DG
Life Sci; 1993; 52(10):845-55. PubMed ID: 8445980
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
